Cargando…
Characterization of triple negative breast cancer gene expression profiles in Mexican patients
Triple negative breast cancer (TNBC) is an aggressive type of cancer that accounts for ~23% of breast tumors in Mexico. In an attempt to understand in an improved way the behavior of TNBC, throughout the years, gene expression in these tumors has been studied. Lehman et al identified 6 subtypes of g...
Autores principales: | Ortiz Valdez, Eric, Rangel-Escareño, Claudia, Matus Santos, Juan Antonio, Vázquez Romo, Rafael, Guijosa, Alberto, Villarreal-Garza, Cynthia, Arrieta, Oscar, Rodríguez-Bautista, Rubén, Caro-Sánchez, Claudia H., Ortega Gómez, Alette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808158/ https://www.ncbi.nlm.nih.gov/pubmed/36605097 http://dx.doi.org/10.3892/mco.2022.2601 |
Ejemplares similares
-
Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior
por: Rodríguez-Bautista, Rubén, et al.
Publicado: (2021) -
Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer
por: Rodríguez Bautista, Rubén, et al.
Publicado: (2018) -
Correction to: Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer
por: Bautista, Rubén Rodríguez, et al.
Publicado: (2018) -
Gene-expression profiles in lung adenocarcinomas related to chronic wood smoke or tobacco exposure
por: Ortega-Gómez, Alette, et al.
Publicado: (2016) -
Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
por: Alvarado-Miranda, Alberto, et al.
Publicado: (2023)